The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support of the Coccidioidomycosis Collaborative Research Centers (CCRCs). The CCRCs are highly collaborative, multi-disciplinary, research centers that conduct clinical and translational research to support the development of a vaccine to combat coccidioidomycosis (Valley fever), a serious and difficult to treat fungal infection endemic in many regions of the United States. Activities to be supported align with the NIAID strategic plan for research to develop a Valley fever vaccine and include (1) addressing gaps in basic Coccidioides research, (2) development of tools and resources, and (3) development of a preventative vaccine. The expectation is that the multi-disciplinary centers will leverage unique research resources and patient populations from endemic regions to advance the field. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Government

• County governments
• City or township governments
• Special district governments
• Federally recognized Native American tribal governments
• Public and Indian housing authorities
• State governments

Nonprofit

• Nonprofits non-higher education with 501(c)(3)
• Other Native American tribal organizations
• Nonprofits non-higher education without 501(c)(3)

Miscellaneous

• Other

Education

• Private institutions of higher education
• Public and state institutions of higher education
• Independent school districts

Business

• For-profit organizations other than small businesses
• Small businesses